Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesOrthopedics/MusculoskeletalKaiser Permanente Shoulder Arthroplasty Coverage U…
    Ask Trek AI about this page
    ModifiedKaiser PermanentePolicy N/A

    Clinical Review Criteria — Shoulder Arthroplasty

    Customize your policy alerts

    Sign up for all Kaiser Permanente policy alerts

    Know when Kaiser Permanente releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Clinical review criteria governing medical necessity determinations for shoulder arthroplasty procedures for Kaiser Foundation Health Plan of Washington members (Medicare and Non‑Medicare), including eligibility criteria, optimization requirements, and required documentation for prior authorization.

    Policy Summary
    PayerKaiser Permanente
    PolicyShoulder Arthroplasty (Clinical Review Criteria)
    Policy CodePolicy N/A
    Change TypeAdoption of KP National/MCG criteriamaterial updates
    Effective Date08/01/2026
    Last ReviewMar 3, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization and submit last 6 months of clinical notes to document failed conservative therapy before scheduling shoulder arthroplasty.
    SourceLink
    POLICY UPDATE CHANGES

    MPC approved to adopt KP National policy for Shoulder Arthroplasty; effective 08/01/2026 (60-day notice required).

    Removed the IP only list.

    Adoption of hybrid MCG criteria KP-S-634 for Shoulder Arthroplasty and KP-S-633 for Shoulder Hemiarthroplasty.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    49Referenced items
    5Procedure codes
    <40BMI threshold
    <8.0HbA1c threshold
    30 daysNicotine-free period
    IncludedCMS references

    Coverage and Medical Necessity Criteria

    Procedure Codes and Clinical Thresholds

    Considered medically necessary when criteria metCPTCovered
    23335Removal of prosthesis, includes debridement and synovectomy when performed; humeral and glenoid components (eg, total shoulder).
    23470Arthroplasty, glenohumeral joint; hemiarthroplasty.
    23472Arthroplasty, glenohumeral joint; total shoulder (glenoid and proximal humeral replacement (eg, total shoulder)).
    23473Revision of total shoulder arthroplasty, including allograft when performed; humeral or glenoid component.
    23474Revision of total shoulder arthroplasty, including allograft when performed; humeral and glenoid component.
    Regulatory citations (no procedure codes listed)mixed
    No codes listed
    inv-10: HbA1c — clinical threshold guidance
    HbA1c thresholdPreferred HbA1c < 8.0; A1c > 8.0 is a relative contraindication — members with A1c above goal must demonstrate active medical management and reduction over 3–6 months or documented shared decision making for case‑by‑case review.
    Optimization periodDocumented attempts to improve glycemic control over 3–6 months required when A1c > goal; show active involvement with medical management and measurable reduction.
    Case‑by‑case reviewIf optimization unsuccessful but adequate efforts are documented, the case may be reviewed on a case‑by‑case basis by a medical director.
    inv-11: BMI — clinical threshold guidance (relative contraindication >40)
    BMI thresholdPreferred BMI < 40; BMI > 40 is a relative contraindication and requires documented optimization efforts (sustained weight loss over 3–6 months or participation in weight loss/exercise program with formal nutritional counseling).
    Optimization evidenceDocumentation must show sustained weight loss over 3–6 months OR stagnant weights despite active participation in a weight loss/exercise program plus formal nutritional counseling.
    If optimization failsIf optimization attempts are unsuccessful, surgeon and patient may proceed with documented shared decision making; cases with adequate efforts may be reviewed case‑by‑case by a medical director.
    inv-12: None in these reference chunks — placeholder key/value
    No threshold listedNo additional numeric clinical thresholds are present in these reference chunks.
    Regulatory referencesThis window contains referenced CMS manuals and regulatory citations but does not add other numeric thresholds.
    Use existing optimization rulesFollow the BMI and HbA1c optimization requirements already stated in the policy for clinical decision making.

    Prior Authorization, Documentation & Provider Responsibilities

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required for the site of service for listed shoulder arthroplasty procedures; use MCG KP-S-634 Care Guideline for medical necessity determinations. Surgery may be performed inpatient or outpatient but prior authorization supports choosing the most appropriate, cost-effective site of service.

    • Prior authorization required for site of service for shoulder arthroplasty procedures
    • MCG KP-S-634 referenced for non-Medicare members; effective through 2026-08-01 for elective surgical procedure level-of-care review
    Documentation Required

    Required Documentation and Denial Risk

    Send clinical documentation to support medical necessity when requesting the service. Failure to provide required documentation or to document trial of conservative therapy may lead to denial.

    Clinical Background

    Shoulder arthroplasty is a surgical procedure that replaces the humeral head and/or glenoid; procedure types addressed in this policy include anatomic total shoulder arthroplasty, reverse total shoulder arthroplasty, hemiarthroplasty, and revision shoulder arthroplasty. Reverse total shoulder arthroplasty uses a reversed ball-and-socket configuration and is commonly indicated for rotator cuff deficiency and related conditions. The policy applies to both inpatient and outpatient settings and identifies specific CPT codes for covered procedures including 23335, 23470, 23472, 23473, and 23474.

    Key Definitions and Guidance

    inv-22: Reverse total shoulder arthroplasty — definition and clinical context
    DefinitionReverse total shoulder arthroplasty: configuration where the mechanical 'socket' is placed into the humeral head and the 'ball' is attached to the glenoid; used for rotator cuff deficiency and other specific indications.
    IndicationsIndicated for massive rotator cuff tear, failed rotator cuff repair, rotator cuff deficient arthropathy, certain fractures with cuff deficiency, failed prior arthroplasty, and other listed conditions.
    Clinical contextMay be performed inpatient or outpatient; prior authorization is required for site of service for listed shoulder arthroplasty procedures per the policy.
    inv-23: Consensus and appropriateness guidance — references to consensus statements and validated algorithms informing appropriateness
    Consensus guidance citedPolicy references consensus statements and validated rehabilitation algorithms (e.g., American Society of Shoulder and Elbow Therapists consensus on rehabilitation for anatomic total shoulder arthroplasty).
    Policy Summary
    PayerKaiser Permanente
    PolicyShoulder Arthroplasty (Clinical Review Criteria)
    Policy CodePolicy N/A
    Change TypeAdoption of KP National/MCG criteriamaterial updates
    Effective Date08/01/2026
    Last ReviewMar 3, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization and submit last 6 months of clinical notes to document failed conservative therapy before scheduling shoulder arthroplasty.
    SourceLink
    On This Page
    Coverage and Medical Necessity CriteriaProcedure Codes and Clinical ThresholdsPrior Authorization, Documentation & Provider ResponsibilitiesClinical BackgroundKey Definitions and Guidance
  1. Required documentation: last 6 months of clinical notes from requesting provider and/or specialist
  2. Failure to document conservative therapy (see conservative therapy requirements) may result in denial
  3. Documentation Required

    Conservative Therapy Requirements

    Conservative (nonoperative) therapy must be tried and failed and documented prior to arthroplasty unless clearly not appropriate. Required elements include an anti-inflammatory medication trial ≥3 weeks (NSAID or acetaminophen or intra-articular corticosteroid as appropriate) and a trial of physical therapy within the last 12 months. If conservative therapy is not appropriate, the medical record must document why (examples: rapid progression of radiographic severity, rapid/progressive flexion contracture, or medical/social factors precluding conservative treatment). Additionally, replacement is supported when there are 3 months of disabling pain and 3 months of functional disability in age-appropriate activities of daily living.

    • Anti-inflammatory medication ≥3 weeks (oral/topical NSAID or acetaminophen) or intra-articular corticosteroid as appropriate
    • Physical therapy trial within last 12 months OR documented reason why conservative therapy is not reasonable
    • Replacement criteria include ≥3 months disabling pain and ≥3 months functional disability
    • Osteonecrosis of the humeral head included as an indication
    Step Therapy

    Step Therapy

    No step therapy instructions are provided in these reference excerpts; no step-therapy program is specified for shoulder arthroplasty in this document.

    • No step therapy instructions present — informational
    Note

    Regulatory Sources Cited

    Regulatory sources informing coverage and claims review include CMS manuals and databases. References cited include the Centers for Medicare & Medicaid Services Medicare Benefit Policy Manual (Chapters 1, 6, 15), the Medicare Program Integrity Manual (Chapter 6, Section 6.5), and the Medicare Coverage Database.

    • CMS Medicare Benefit Policy Manual Chapter 1, 6, and 15
    • CMS Medicare Program Integrity Manual Chapter 6, Section 6.5
    • Medicare Coverage Database
    Note

    Authorization / Denial Criteria (Informational)

    There are no explicit operational authorization or denial criteria presented in these reference excerpts beyond the medical necessity and documentation requirements above; use the criteria in this policy and referenced MCG guideline for final determinations.

    • No explicit separate authorization/denial algorithm provided in these excerpts — rely on policy criteria and documentation standards
    Supporting literatureMultiple peer‑reviewed articles and reviews are cited addressing indications, risk factors, prevention, and management of complications after shoulder arthroplasty.
    Regulatory and manual sourcesCMS manuals and regulatory citations (Medicare Benefit Policy Manual, Program Integrity Manual, and CFR references) are included to inform appropriateness and claims review.